As stated above, the diagnosis of CMV retinitis relies on the fundus appearance. However, in the early stages of disease and in patients with atypical features, it is difficult to differentiate between retinitis caused by CMV and retinitis associated with the other herpesviruses. Discrimination between viral and non-viral pathogens such as Toxoplasma gondii can be particularly difficult by clinical examination alone. Rapid accurate diagnosis of ocular CMV infection and the prompt initiation of appropriate therapy is essential both for the preservation of sight and the improved survival of the patient. Furthermore, the personal cost to the patient and the waste of resources associated with the use of multiple antibiotic and antiviral therapies prompts the development of rapid, sensitive, and specific diagnostic tests for ocular pathogens such as CMV. Appropriate biopsy site selection is essential with direct detection methods and ideally in these infections this would be the retina, but for obvious reasons retinal tissue is not usually available. Although the isolation of CMV from the blood and peripheral sites confirms that a patient has active viral replication,6 these findings are not diagnostic for target organ disease. Indeed, the majority of AIDS patients may have culturable CMV viraemia without evidence of ocular disease. Viral culture of ocular fluids has not been useful in the past because of the minute sample volume which is available and the relative insensitivity of in vitro propagation, perhaps as a result of neutralising antibodies. The technique of PCR7 8 allows the amplification of nucleic acid sequences to easily detectable levels, making the direct detection of viral genome in small ocular fluid samples a possibility for the first time. In Doornenbal et al's study, aqueous, vitreous, and subretinal fluid samples were taken at various times in the disease process, which for clinical reasons may have been unavoidable but such samples are not directly comparable.9
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The conclusion in Doornenbal and colleagues' paper that PCR based assays applied to ocular fluids are specific and sensitive tools in the diagnosis of CMV retinitis in patients where the clinical diagnosis is unclear, confirms findings in two recent studies using standardised PCR based assays.'0 1 As Doornenbal and colleagues state, it is now time to develop generally standardised protocols and intercentre quality control programmes to allow both better comparison of results from different laboratories and the sharing of data in the case of the rarer ocular infections.
The unique contribution of this paper is to compare these PCR based assays with antibody based assays in the form of the Goldmann-Witmer quotient (GWq). This method determines the ratio of antibody titres against suspected intraocular pathogens in ocular fluids and serum to the total amount of IgG, and has been applied successfully in the past to patients with a diagnosis of ocular toxoplasmosis and ARN in the immunocompetent patient.'2 13 As such, this was an appropriate choice of assay for comparison with clinical diagnosis and PCR based assays, but as the authors themselves point out there was little expectation of it proving to be useful in patients with AIDS, as for a variety of reasons 
